QV Bioelectronics: Funding, Investors & Team (Oct 2026)
QV Bioelectronics is dedicated to improving the lives of brain tumor patients by developing a unique electric field therapy implant called GRACE, in collaboration with leading neurosurgeons in the UK. The goal is to increase life expectancy without compromising quality of life for patients with glioblastoma, a particularly difficult-to-treat brain tumor. Co-founder Dr. Richard Fu, along with Dr. Chris Bullock, created GRACE to address the lack of effective treatments for this type of tumor. The company has received significant financial support and investments to further develop their innovative solution and has assembled a team of experts with years of experience in bringing GRACE to the clinic.
QV Bioelectronics has raised $10.1M across 3 funding rounds on record, the most recent an undisclosed round of $6.0M announced in Jan 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
QV Bioelectronics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
QV Bioelectronics Funding Rounds
QV Bioelectronics raised $2.4M in a Seed announced in Jan 2023.
2.3 years later, an undisclosed round of $1.7M was announced in May 2025.
8 months later, an undisclosed round of $6.0M was announced in Jan 2026.
QV Bioelectronics Founders and Leadership Team
Contact details for the QV Bioelectronics team: 2 of 2 have an email address on file.
Start 14-day free trial →QV Bioelectronics Funding Compared to Other Biotechnology Startups
QV Bioelectronics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like QV Bioelectronics in Biotechnology and Manchester
Companies Similar to QV Bioelectronics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
QV Bioelectronics Funding FAQs
What does QV Bioelectronics do?
QV Bioelectronics is dedicated to improving the lives of brain tumor patients by developing a unique electric field therapy implant called GRACE, in collaboration with leading neurosurgeons in the UK. The goal is to increase life expectancy without compromising quality of life for patients with glioblastoma, a particularly difficult-to-treat brain tumor. Co-founder Dr. Richard Fu, along with Dr. Chris Bullock, created GRACE to address the lack of effective treatments for this type of tumor. The company has received significant financial support and investments to further develop their innovative solution and has assembled a team of experts with years of experience in bringing GRACE to the clinic.
How much funding has QV Bioelectronics raised?
QV Bioelectronics has raised $10.1M across 3 rounds on record. The most recent is an undisclosed round of $6.0M announced in Jan 2026.
When did QV Bioelectronics last raise funding?
QV Bioelectronics' most recent funding round on record is an undisclosed round of $6.0M, announced in Jan 2026.
Who founded QV Bioelectronics?
FundedIQ lists Richard Fu (Founder) at QV Bioelectronics.
Who is the CEO of QV Bioelectronics?
Chris Bullock is listed as CEO at QV Bioelectronics.
Where is QV Bioelectronics headquartered?
QV Bioelectronics is based in Manchester, United Kingdom.
How many employees does QV Bioelectronics have?
QV Bioelectronics is in the 11-50 employee band.
How does QV Bioelectronics' funding compare to other Biotechnology startups?
QV Bioelectronics' latest round of $6.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's QV Bioelectronics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QV Bioelectronics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.